Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Appl Microbiol. 2014 Aug 23;117(5):1253–1259. doi: 10.1111/jam.12618

Figure 1. Dose-dependent inhibition of HSV-2 multiplication by subtilosin.

Figure 1

Vero cells infected with HSV-2 (m.o.i. =1) were incubated with different concentrations of subtilosin. At 24 h p.i. virus yield was quantified by plaque assay. Data represent mean values from duplicate determinations ± standard deviation (SD).